Praluzatamab is a monoclonal antibody specifically designed to target the activated leukocyte cell adhesion molecule (ALCAM), also known as CD116. This antibody has been engineered to facilitate the development of antibody-drug conjugates, such as Praluzatamab ravtansine, enhancing its utility in targeted cancer therapy. Praluzatamab is primarily utilized in oncological research, where it serves as a critical tool in the investigation of cancer pathogenesis and the development of novel therapeutic strategies.
Praluzatamab is a monoclonal antibody specifically designed to target the activated leukocyte cell adhesion molecule (ALCAM), also known as CD116. This antibody has been engineered to facilitate the development of antibody-drug conjugates, such as Praluzatamab ravtansine, enhancing its utility in targeted cancer therapy. Praluzatamab is primarily utilized in oncological research, where it serves as a critical tool in the investigation of cancer pathogenesis and the development of novel therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
